Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Neo adjuvant chemo-radiotherapy and rectal cancer: can India follow the West?

Bansal V, Bhutani R, Doval D, Kumar K, Pande P, Kumar G.

J Cancer Res Ther. 2012 Apr-Jun;8(2):209-14. doi: 10.4103/0973-1482.98972.

2.

Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.

Cambray i Amenós M, Navarro García M, Martí Ragué J, Pareja Fernández L, Pera Fábregas J.

Clin Transl Oncol. 2007 Mar;9(3):183-91.

PMID:
17403630
3.

A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.

Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.

Ann Surg Oncol. 2008 Dec;15(12):3471-7. doi: 10.1245/s10434-008-0149-y. Epub 2008 Oct 10.

PMID:
18846402
4.

Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.

Wolthuis AM, Penninckx F, Haustermans K, De Hertogh G, Fieuws S, Van Cutsem E, D'Hoore A.

Ann Surg Oncol. 2012 Sep;19(9):2833-41. doi: 10.1245/s10434-012-2327-1. Epub 2012 Mar 27.

PMID:
22451236
5.

Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.

Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ.

Dis Colon Rectum. 2004 Dec;47(12):2025-31.

PMID:
15657650
6.

[Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].

Cao WG, Zhao R, Xi WQ, Ma T, Li H, Xu HP, Che JF, Jin YN.

Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):225-7. Chinese.

PMID:
17649643
7.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
8.

A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.

Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, Gambacorta MA, Genovesi D, Kodner IJ, Picus J, Ratkin GA, Read TE.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1299-308.

PMID:
11483342
9.

Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.

Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB.

Jpn J Clin Oncol. 2008 Feb;38(2):112-21. doi: 10.1093/jjco/hym164. Epub 2008 Feb 8.

PMID:
18263881
10.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
11.

Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).

Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.

Acta Oncol. 2008;47(3):428-33. doi: 10.1080/02841860701798866.

PMID:
18348002
12.

Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

Dolinsky CM, Mahmoud NN, Mick R, Sun W, Whittington RW, Solin LJ, Haller DG, Giantonio BJ, O'Dwyer PJ, Rosato EF, Fry RD, Metz JM.

J Surg Oncol. 2007 Sep 1;96(3):207-12.

PMID:
17443718
13.

Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.

Kim JW, Kim YB, Choi JJ, Koom WS, Kim H, Kim NK, Ahn JB, Lee I, Cho JH, Keum KC.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e577-84. doi: 10.1016/j.ijrobp.2012.07.2371. Epub 2012 Sep 14.

PMID:
22981710
14.

The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.

Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):84-9.

PMID:
12909219
15.

Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.

Wolthuis AM, Penninckx F, Haustermans K, Ectors N, Van Cutsem E, D'Hoore A.

Ann Surg Oncol. 2011 Mar;18(3):684-90. doi: 10.1245/s10434-010-1324-5. Epub 2010 Sep 15.

PMID:
20842458
16.

Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?

Jung KU, Kim HC, Park JO, Park YS, Park HC, Choi DH, Cho YB, Yun SH, Lee WY, Chun HK.

J Surg Oncol. 2015 Mar 15;111(4):439-44. doi: 10.1002/jso.23835. Epub 2014 Dec 9.

PMID:
25488390
17.

Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.

Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T.

Ann Surg. 2007 Nov;246(5):754-62.

PMID:
17968166
18.

Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer.

Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1158-63.

PMID:
18795649
19.

Randomized trial of postoperative adjuvant therapy in Stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: 10-year follow-up.

Kim TW, Lee JH, Lee JH, Ahn JH, Kang YK, Lee KH, Yu CS, Kim JH, Ahn SD, Kim WK, Kim JC, Lee JS.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1025-31. doi: 10.1016/j.ijrobp.2010.07.012. Epub 2010 Oct 6.

PMID:
20932669
20.

Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy?

Patel JA, Fleshman JW, Hunt SR, Safar B, Birnbaum EH, Lin AY, Mutch MG.

Dis Colon Rectum. 2012 Mar;55(3):249-55. doi: 10.1097/DCR.0b013e3182411a8f.

PMID:
22469790

Supplemental Content

Support Center